San Diego-primarily based Viking Therapeutics marked itself as a significant competitor while in the weight loss drug marketplace in February just after revealing promising info from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection As well as in M